MedTrace Logo

Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo

NCT04171427 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-11-20

No results posted yet for this study

Summary

* Study in proof of concept;
* Double blind study;
* Comparative study, versus placebo in intra-individual
* Three parallel groups testing different dosages / combinations of treatments
* Randomized.

Conditions

  • Vitiligo

Interventions

OTHER

Lithium liposome

Cosmetic product

OTHER

Placebo

Cosmetic product vehicle

Sponsors & Collaborators

  • Laboratoire Dermatologique ACM

    lead INDUSTRY

Principal Investigators

  • Samy FENNICHE · Hbib Thamer Hosptal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-21
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04171427 on ClinicalTrials.gov